loadpatents
name:-0.070514917373657
name:-0.043846130371094
name:-0.0021519660949707
CAMERON; Beatrice Patent Filings

CAMERON; Beatrice

Patent Applications and Registrations

Patent applications and USPTO patent grants for CAMERON; Beatrice.The latest application filed is for "anti-cd38 antibodies and methods of use".

Company Profile
1.43.62
  • CAMERON; Beatrice - Paris FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-cd38 Antibodies And Methods Of Use
App 20220275102 - CAMERON; Beatrice ;   et al.
2022-09-01
Anti-CD38 antibodies and methods of use
Grant 11,365,261 - Cameron , et al. June 21, 2
2022-06-21
Anti-CEACAM5 antibodies and uses thereof
Grant 11,332,542 - Berne , et al. May 17, 2
2022-05-17
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Uses
App 20220073629 - Lee; Renata ;   et al.
2022-03-10
Anti-cd38 Antibodies And Methods Of Use
App 20220041746 - CAMERON; Beatrice ;   et al.
2022-02-10
Anti-CD38 antibodies and methods of use
Grant 11,186,649 - Wu , et al. November 30, 2
2021-11-30
Trispecific Binding Proteins, Methods, And Uses Thereof
App 20200399369 - ASOKAN; Mangaiarkarasi ;   et al.
2020-12-24
Anti-cd38 Antibodies And Formulations
App 20200399391 - CHIRON BLONDEL; Marielle ;   et al.
2020-12-24
Trispecific Anti-cd38, Anti-cd28, And Anti-cd3 Binding Proteins And Methods Of Use For Treating Viral Infection
App 20200140552 - WU; Lan ;   et al.
2020-05-07
Anti-ceacam5 Antibodies And Uses Thereof
App 20200102401 - BERNE; Pierre-Francois ;   et al.
2020-04-02
Anti-CEACAM5 antibodies and uses thereof
Grant 10,457,739 - Berne , et al. Oc
2019-10-29
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20190119365 - Baurin; Nicolas ;   et al.
2019-04-25
Anti-cd38 Antibodies And Methods Of Use
App 20190106504 - WU; Lan ;   et al.
2019-04-11
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Grant 10,112,991 - Baurin , et al. October 30, 2
2018-10-30
Anti-lamp1 Antibodies And Antibody Drug Conjugates, And Uses Thereof
App 20180142032 - BAUDAT; Yves ;   et al.
2018-05-24
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Use
App 20180100019 - Lee; Renata ;   et al.
2018-04-12
Anti-ceacam5 Antibodies And Uses Thereof
App 20180022817 - BERNE; Pierre-Francois ;   et al.
2018-01-25
Humanized anti-CXCR5 antibodies, derivatives thereof and their uses
Grant 9,815,902 - Lee , et al. November 14, 2
2017-11-14
Anti-LAMP1 antibodies and antibody drug conjugates, and uses thereof
Grant 9,809,653 - Baudat , et al. November 7, 2
2017-11-07
Anti-CEACAM5 antibodies and uses thereof
Grant 9,617,345 - Berne , et al. April 11, 2
2017-04-11
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Uses
App 20170044263 - Lee; Renata ;   et al.
2017-02-16
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20160368977 - Baurin; Nicolas ;   et al.
2016-12-22
Robo1-Fc fusion protein and use thereof for treating tumours
Grant 9,493,529 - Blanche , et al. November 15, 2
2016-11-15
Anti-lamp1 Antibodies And Antibody Drug Conjugates, And Uses Thereof
App 20160280793 - BAUDAT; Yves ;   et al.
2016-09-29
Antagonist antibodies and their fab fragments against GPVI and uses thereof
Grant 9,441,040 - Baurin , et al. September 13, 2
2016-09-13
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Grant 9,382,312 - Baurin , et al. July 5, 2
2016-07-05
Peptide Or Peptide Complex Binding To Alpha2 Integrin And Methods And Uses Involving The Same
App 20160176970 - Corvey; Carsten ;   et al.
2016-06-23
Anti-ceacam5 Antibodies And Uses Thereof
App 20160108131 - BERNE; Pierre-Francois ;   et al.
2016-04-21
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
Grant 9,243,067 - Lee , et al. January 26, 2
2016-01-26
Peptide or peptide complex binding to ALPHA2 integrin and methods and uses involving the same
Grant 9,234,039 - Corvey , et al. January 12, 2
2016-01-12
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
Grant 9,228,019 - Lee , et al. January 5, 2
2016-01-05
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
Grant 9,175,087 - Lee , et al. November 3, 2
2015-11-03
Novel Antagonist Antibodies And Their Fab Fragments Against Gpvi And Uses Thereof
App 20150098939 - BAURIN; Nicolas ;   et al.
2015-04-09
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
Grant 8,980,262 - Lee , et al. March 17, 2
2015-03-17
Antagonist antibodies and their fab fragments against GPVI and uses thereof
Grant 8,852,593 - Baurin , et al. October 7, 2
2014-10-07
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20140105890 - BAURIN; Nicolas ;   et al.
2014-04-17
Method Of Production Of Sialylated Antibodies
App 20140046032 - Blanche; Francis ;   et al.
2014-02-13
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
Grant 8,647,622 - Lee , et al. February 11, 2
2014-02-11
Modified Soluble Fgf Receptor Fc Fusions Method
App 20140030265 - BLANCHE; Francis ;   et al.
2014-01-30
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Grant 8,614,299 - Baurin , et al. December 24, 2
2013-12-24
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use
App 20130251714 - Lee; Renata ;   et al.
2013-09-26
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use
App 20130243793 - Lee; Renata ;   et al.
2013-09-19
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use
App 20130246035 - Lee; Renata ;   et al.
2013-09-19
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use
App 20130243783 - Lee; Renata ;   et al.
2013-09-19
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use
App 20130236476 - Lee; Renata ;   et al.
2013-09-12
Modified soluble FGF receptor Fc fusions method
Grant 8,481,487 - Blanche , et al. July 9, 2
2013-07-09
Peptide Or Peptide Complex Binding To 2 Integrin And Methods And Uses Involving The Same
App 20130156786 - Corvey; Carsten ;   et al.
2013-06-20
Anti-gitr Antibodies
App 20130108641 - Baurin; Nicolas ;   et al.
2013-05-02
Purification of a triple helix formation with an immobilized obligonucleotide
Grant 8,399,636 - Crouzet , et al. March 19, 2
2013-03-19
Robo1-fc Fusion Protein And Use Thereof For Treating Tumours
App 20130039912 - Blanche; Francis ;   et al.
2013-02-14
Novel Antagonist Antibodies And Their Fab Fragments Against Gpvi And Uses Thereof
App 20120244152 - Baurin; Nicolas ;   et al.
2012-09-27
Modified Soluble Fgf Receptor Fc Fusions With Improved Biological Activity
App 20120195851 - BLANCHE; Francis ;   et al.
2012-08-02
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20120177639 - Baurin; Nicolas ;   et al.
2012-07-12
Modified soluble FGF receptor Fc fusions with improved biological activity
Grant 8,119,770 - Blanche , et al. February 21, 2
2012-02-21
Purification Of A Triple Helix Formation With An Immobilized Oligonucleotide
App 20110319605 - CROUZET; Joel ;   et al.
2011-12-29
Purification of a triple helix formation with an immobilized oligonucleotide
Grant 8,017,744 - Crouzet , et al. September 13, 2
2011-09-13
Fgf-r4 Receptor-specific Antagonists
App 20110150903 - Baurin; Nicolas ;   et al.
2011-06-23
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
App 20110027266 - Lee; Renata ;   et al.
2011-02-03
Modified Soluble Fgf Receptor Fc Fusions Wsith Improved Biological Activity
App 20100061979 - Blanche; Francis ;   et al.
2010-03-11
Purification Of A Triple Helix Formation With An Immobilized Oligonucleotide
App 20100010208 - CROUZET; Joel ;   et al.
2010-01-14
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
Grant 7,514,218 - Blanche , et al. April 7, 2
2009-04-07
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
App 20080064031 - Blanche; Francis ;   et al.
2008-03-13
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
App 20060205000 - Blanche; Francis ;   et al.
2006-09-14
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
Grant 7,052,838 - Blanche , et al. May 30, 2
2006-05-30
Purification of a triple heli formation with an immobilized oligonucleotide
Grant 7,038,026 - Crouzet , et al. May 2, 2
2006-05-02
Purification of a triple helix formation with an immobilized oligonucleotide
App 20060036085 - Crouzet; Joel ;   et al.
2006-02-16
Methods of increasing the production of cobalamins using cob gene expression
App 20060019352 - Blanche; Francis ;   et al.
2006-01-26
DNA molecules, preparation and use in gene therapy
Grant 6,825,012 - Blanche , et al. November 30, 2
2004-11-30
Novel topoisomerase IV, corresponding nucleotide sequences and uses thereof
App 20040077005 - Blanche, Francis ;   et al.
2004-04-22
Kringle polypeptides and methods for using them to inhibit angiogenesis
App 20040052777 - Nesbit, Mark ;   et al.
2004-03-18
Abrogen polypeptides, nucleic acids encoding them and methods for using them to inhibit angiogenesis
App 20040052810 - Nesbit, Mark ;   et al.
2004-03-18
Methods of increasing the production of cobalamins using cob gene expression
Grant 6,656,709 - Blanche , et al. December 2, 2
2003-12-02
Cells with altered betaine catabolism and their use in producing metabolites or enzymes
Grant RE38,331 - Cameron , et al. November 25, 2
2003-11-25
Topoisomerase IV, corresponding nucleotide sequences and uses thereof
Grant 6,649,394 - Blanche , et al. November 18, 2
2003-11-18
Purification of a triple heli formation with an immobilized oligonucleotide
App 20030186268 - Crouzet, Joel ;   et al.
2003-10-02
Method of separating viral particles
App 20030170710 - Blanche, Francis ;   et al.
2003-09-11
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
App 20030165876 - Blanche, Francis ;   et al.
2003-09-04
Circular DNA expression cassettes for gene transfer
App 20030104444 - Crouzet, Joel ;   et al.
2003-06-05
Method of separating viral particles
Grant 6,537,793 - Blanche , et al. March 25, 2
2003-03-25
DNA molecules, preparation and use in gene therapy
App 20030032092 - Blanche, Francis ;   et al.
2003-02-13
Method for producing therapeutic DNA
App 20020187527 - Crouzet, Joel ;   et al.
2002-12-12
Circular DNA expression cassettes for gene transfer
Grant 6,492,164 - Crouzet , et al. December 10, 2
2002-12-10
Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy
App 20020102247 - Crouzet, Joel ;   et al.
2002-08-01
Method for producing methylated DNA
Grant 6,410,273 - Crouzet , et al. June 25, 2
2002-06-25
Method of separating viral particles
App 20020037565 - Blanche, Francis ;   et al.
2002-03-28
Pharmaceutical composition useful for nucleic acid transfection, and use thereof
Grant 6,153,597 - Blanche , et al. November 28, 2
2000-11-28
Circular DNA expression cassettes for in vivo gene transfer
Grant 6,143,530 - Crouzet , et al. November 7, 2
2000-11-07
Cells with altered betaine catabolism and their use in producing metabolites or enzymes
Grant 5,691,163 - Cameron , et al. November 25, 1
1997-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed